Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Pembrolizumab as a promising intervention for advanced penile cancer.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Brazilian Society of Urology Country of Publication: Brazil NLM ID: 101158091 Publication Model: Print Cited Medium: Internet ISSN: 1677-6119 (Electronic) Linking ISSN: 16775538 NLM ISO Abbreviation: Int Braz J Urol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Rio de Janerio, RJ, Brazil : Brazilian Society of Urology, [2002]-
    • Subject Terms:
      Lung Neoplasms* ; Penile Neoplasms*/drug therapy; Antibodies, Monoclonal, Humanized/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; Humans ; Male
    • Abstract:
      Competing Interests: None declared.
    • References:
      J Clin Med. 2020 Oct 17;9(10):. (PMID: 33080912)
      Nat Rev Dis Primers. 2021 Feb 11;7(1):11. (PMID: 33574340)
      Front Oncol. 2020 Dec 23;10:615298. (PMID: 33425770)
      Transl Androl Urol. 2017 Oct;6(5):848-854. (PMID: 29184782)
      Ann Oncol. 2016 Sep;27(9):1706-12. (PMID: 27217541)
      Invest New Drugs. 2021 Oct;39(5):1405-1410. (PMID: 33770291)
      J Urol. 2020 Jun;203(6):1147-1155. (PMID: 31928407)
      Semin Oncol. 2020 Dec;47(6):367-379. (PMID: 33160642)
      Rev Panam Salud Publica. 2017 Nov 30;41:e117. (PMID: 31384255)
      Future Sci OA. 2021 May 21;7(7):FSO714. (PMID: 34258024)
      Ann Oncol. 2020 Sep;31(9):1115-1118. (PMID: 32771306)
      Lancet Oncol. 2020 Oct;21(10):1353-1365. (PMID: 32919526)
    • Accession Number:
      0 (Antibodies, Monoclonal, Humanized)
      DPT0O3T46P (pembrolizumab)
    • Publication Date:
      Date Created: 20220404 Date Completed: 20220524 Latest Revision: 20220723
    • Publication Date:
      20240105
    • Accession Number:
      PMC9306374
    • Accession Number:
      10.1590/S1677-5538.IBJU.2022.99.17
    • Accession Number:
      35373954